Neuromuscular Diseases Care in the Era of COVID-19
Open accessAbstract
The COVID-19 pandemic has pushed health systems to their limit and forced readjustment of standards of care for different pathologies. Management of neuromuscular diseases becomes a challenge since most of them are chronic, disabling, progressive, and/or require immunosuppressive drugs. There are three main aspects of COVID-19 that affect neuromuscular diseases care. The first one relates to how SARS-CoV2 directly affects different neuromuscular pathologies. Respiratory weakness, as seen in myasthenia gravis, amyotrophic lateral sclerosis, and myopathies, and the use of immunomodulatory drugs (Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy) make this group of patients potentially more vulnerable. Secondly, safety measures also affect proper care, limiting care continuity, and physical rehabilitation (one of the essential aspects of myopathies treatment). Telemedicine can partially solve the problem allowing for a continuum of close care, avoiding unnecessary visits, and even guaranteeing the attention of professionals from tertiary care centers. However, one of the crucial steps in neuromuscular diseases is diagnosis, and in most scenarios, more than one face-to-face visit is needed. Lastly, the global COVID-19 situation will also have an economic impact on patients and their families. This situation is of particular concern given that neuromuscular diseases already present difficulties due to the scarcity of resources in terms of public healthcare and research.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Opportunities were considered and offered to overcome some problems through telemedicine and new measurements.
“Therefore, opportunities were considered and offered to overcome some of these problems through telemedicine [23] and new measurements [24–29].”
From Life Experiences in Neuromuscular Tracheotomized Patients in Times of Covid-19 (2023) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267 · see citing works
Neurological associations of COVID-19
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., Kneen, R., Defres, S., Sejvar, J., & Solomon, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30221-0 · Cited by 2,156 · see citing works
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012410 · Cited by 1,625 · see citing works
Louapre, C., Collongues, N., Stankoff, B., Giannesini, C., Papeix, C., Bensa, C., Deschamps, R., Créange, A., Wahab, A., Pelletier, J., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2581 · Cited by 455 · see citing works
Neurological Manifestations of COVID‐19: A systematic review and current update
Whittaker, A., Anson, M., & Harky, A. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13266 · Cited by 430 · see citing works
Abu‐Rumeileh, S., Abdelhak, A., Foschi, M., Tumani, H., & Otto, M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10124-x · Cited by 428 · see citing works
COVID-19 and neuromuscular disorders
Guidon, A. C., & Amato, A. A. (2020) · Neurology · doi:10.1212/wnl.0000000000009566 · Cited by 276 · see citing works
Neuromuscular presentations in patients with COVID-19
Paliwal, V. K., Garg, R. K., Gupta, A., & Tejan, N. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04708-8 · Cited by 266 · see citing works
Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease
Dalakas, M. C. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000781 · Cited by 254 · see citing works
Dexamethasone in the management of covid -19
Johnson, R. M., & Vinetz, J. M. (2020) · BMJ · doi:10.1136/bmj.m2648 · Cited by 200 · see citing works
Myasthenia Gravis Associated With SARS-CoV-2 Infection
Restivo, D. A., Centonze, D., Alesina, A., & Marchese‐Ragona, R. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0845 · Cited by 180 · see citing works
Rondaan, C., Furer, V., Heijstek, M. W., Agmon-Levin, N., Bijl, M., Breedveld, F. C., D’Amelio, R., Dougados, M., Kapetanovic, M. C., van Laar, J. M., et al. (2019) · RMD Open · doi:10.1136/rmdopen-2019-001035 · Cited by 154 · see citing works
Myasthenia gravis and infectious disease
Gilhus, N. E., Romi, F. R., Hong, Y., & SKEIE, G. O. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8751-9 · Cited by 147 · see citing works
Uncini, A., Vallat, J., & Jacobs, B. C. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324491 · Cited by 136 · see citing works
Disease burden of spinal muscular atrophy in Germany
Klug, C., Schreiber‐Katz, O., Thiele, S., Schorling, E., Zowe, J., Reilich, P., Walter, M. C., & Nagels, K. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0424-0 · Cited by 128 · see citing works
COVID ‐19 in patients with myasthenia gravis
Anand, P., Slama, M. C. C., Kaku, M. C., Ong, C. J., Cervantes-Arslanian, A. M., Zhou, L., David, W. S., & Guidon, A. C. (2020) · Muscle & Nerve · doi:10.1002/mus.26918 · Cited by 116 · see citing works
Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis
Guptill, J. T., Juel, V. C., Massey, J. M., Anderson, A., Chopra, M., Yi, J. S., Esfandiari, E., Buchanan, T. J., Smith, B., Atherfold, P. A., et al. (2016) · Autoimmunity · doi:10.1080/08916934.2016.1214823 · Cited by 114 · see citing works
Louapre, C., Collongues, N., Stankoff, B., Giannesini, C., Papeix, C., Bensa, C., Deschamps, R., Créange, A., Wahab, A., Pelletier, J., et al. (2020) · Multiple Sclerosis Journal · Cited by 103 · see citing works
Stefano, V. D., Battaglia, G., Giustino, V., Gagliardo, A., D’Aleo, M., Giannini, O., Palma, A., & Brighina, F. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10064-6 · Cited by 99 · see citing works
Cranial neuropathies and COVID-19
Costello, F., & Dalakas, M. C. (2020) · Neurology · doi:10.1212/wnl.0000000000009921 · Cited by 95 · see citing works
Feldman, C. H., Marty, F. M., Winkelmayer, W. C., Guan, H., Franklin, J. M., Solomon, D. H., Costenbader, K. H., & Kim, S. C. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39849 · Cited by 87 · see citing works
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
Fan, M., Qiu, W., Bu, B., Xu, Y., Yang, H., Huang, D., Lau, A. Y. L., Guo, J., Zhang, M., Zhang, X., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000787 · Cited by 86 · see citing works
Critical illness myopathy after COVID-19
Bagnato, S., Boccagni, C., Marino, G., Prestandrea, C., D’Agostino, T., & Rubino, F. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.072 · Cited by 85 · see citing works
Solé, G., Salort‐Campana, E., Péréon, Y., Stojkovic, T., Wahbi, K., Cintas, P., Adams, D., Laforêt, P., Tiffreau, V., Desguerre, I., et al. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.04.004 · Cited by 83 · see citing works
Critical illness myopathy as a consequence of Covid-19 infection
Tankişi, H., Tankisi, A., Harbo, T., Markvardsen, L. H., Andersen, H., & Pedersen, T. H. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.06.003 · Cited by 80 · see citing works
Ueber das „intermittirende Hinken“ und andere nervöse Störungen in Folge von Gefässerkrankungen
Erb, W. (1898) · Journal of Neurology · doi:10.1007/bf01840523 · Cited by 77 · see citing works
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID ‐19 pandemic
Veerapandiyan, A., Wagner, K. R., Apkon, S. D., McDonald, C. M., Mathews, K. D., Parsons, J. A., Wong, B. L. Y., Eichinger, K. J., Shieh, P. B., Butterfield, R. J., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.26902 · Cited by 69 · see citing works
Serious infections in patients with myasthenia gravis: population‐based cohort study
Kassardjian, C. D., Widdifield, J., Paterson, J. M., Kopp, A., Nagamuthu, C., Barnett, C., Tu, K., & Breiner, A. (2020) · European Journal of Neurology · doi:10.1111/ene.14153 · Cited by 61 · see citing works
Andrews, J. A., Berry, J. D., Baloh, R. H., Carberry, N., Cudkowicz, M. E., Dedi, B., Glass, J., Maragakis, N. J., Miller, T. M., Paganoni, S., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.26989 · Cited by 57 · see citing works
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
Ramaswamy, S. B., & Govindarajan, R. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200520 · Cited by 49 · see citing works
Schiefferdec, P., & Schultze, F. (1903) · Journal of Neurology · doi:10.1007/bf02074571 · Cited by 47 · see citing works
Description of 3 patients with myasthenia gravis and COVID-19
Rein, N., Haham, N., Orenbuch‐Harroch, E., Romain, M., Argov, Z., Vaknin‐Dembinsky, A., & Gotkine, M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117053 · Cited by 45 · see citing works
Consonni, M., Telesca, A., Bella, E. D., Bersano, E., & Lauria, G. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10080-6 · Cited by 44 · see citing works
Scrutinizing enrollment in ALS clinical trials: Room for improvement?
Bedlack, R., Pastula, D. M., Welsh, E., Pulley, D., & Cudkowicz, M. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802195913 · Cited by 43 · see citing works
COVID-19 and psoriasis: biologic treatment and challenges
Ebrahimi, A., Sayad, B., & Rahimi, Z. (2020) · Journal of Dermatological Treatment · doi:10.1080/09546634.2020.1789051 · Cited by 42 · see citing works
Spinal muscular atrophy care in the COVID‐19 pandemic era
Veerapandiyan, A., Connolly, A. M., Finkel, R. S., Arya, K., Mathews, K. D., Smith, E. C., Castro, D., Butterfield, R. J., Parsons, J. A., Servais, L., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.26903 · Cited by 36 · see citing works
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis
Paganoni, S., van de Rijn, M., Drake, K., Burke, K. M., Doyle, M., Ellrodt, A. S., Nicholson, K., Atassi, N., Marchi, F. D., Babu, S., et al. (2019) · Muscle & Nerve · doi:10.1002/mus.26606 · Cited by 35 · see citing works
Lucia, N. D., Ausiello, F. P., Spisto, M., Manganelli, F., Salvatore, E., & Dubbioso, R. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04592-2 · Cited by 27 · see citing works
The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
Kelly, M. L., Lavrov, A., Garcia‐Gancedo, L., Parr, J., Hart, R., Chiwera, T., Shaw, C. E., Al‐Chalabi, A., Marsden, R., Turner, M. R., et al. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1773501 · Cited by 23 · see citing works
Klinische und anatomische Beiträge zur Lehre von der spinalen Hemiplegie
Mann, L. (1896) · Journal of Neurology · doi:10.1007/bf01674438 · Cited by 22 · see citing works
Camacho, A., Esteban‐Pérez, J., & Paradas, C. (2015) · Neurología · doi:10.1016/j.nrl.2015.02.003 · Cited by 21 · see citing works
Management challenges for chronic dysimmune neuropathies during the COVID ‐19 pandemic
Rajabally, Y. A., Goedee, H. S., Attarian, S., & Hartung, H. (2020) · Muscle & Nerve · doi:10.1002/mus.26896 · Cited by 21 · see citing works
on behalf of SIN, S. A. A., Dubbioso, R., Nobile‐Orazio, E., Manganelli, F., Santoro, L., Briani, C., Cocito, D., Tedeschi, G., Lazzaro, V. D., & Fabrizi, G. M. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04448-9 · Cited by 21 · see citing works
Studien zur Pathologie und pathologischen Anatomie der Rückenmarkscompression bei Wirbelcaries
Fickler, A. (1899) · Journal of Neurology · doi:10.1007/bf01667473 · Cited by 18 · see citing works
Die multiple Sklerose des Centralnervensystems
Hoffmann, J. (1901) · Journal of Neurology · doi:10.1007/bf01844205 · Cited by 18 · see citing works
Guidance for resumption of routine electrodiagnostic testing during the COVID ‐19 pandemic
Desai, U., Kassardjian, C. D., Toro, D. D., Gleveckas‐Martens, N., Srinivasan, J., Venesy, D. A., & Narayanaswami, P. (2020) · Muscle & Nerve · doi:10.1002/mus.26990 · Cited by 18 · see citing works
Camacho, A., Esteban‐Pérez, J., & Paradas, C. (2017) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.02.006 · Cited by 12 · see citing works
Not only pulmonary rehabilitation for critically ill patients with COVID-19
Estraneo, A., Ciapetti, M., Gaudiosi, C., & Grippo, A. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10077-1 · Cited by 8 · see citing works
High-dose immunoglobulin pulse therapy and risk of Covid19 infection
Prada, V., Benedetti, L., Cocito, D., Briani, C., Nobile‐Orazio, E., Gallia, F., Antonini, G., Manganelli, F., Fabrizi, G. M., Germano, F., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10146-5 · Cited by 7 · see citing works
Young, E., Manta, D., Sah, B. P., & Brooks, B. R. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116893 · Cited by 5 · see citing works
Vakil-Gilani, K., & O’Rourke, K. S. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05184-3 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
How to manage with telemedicine people with neuromuscular diseases?
Spina, E., Trojsi, F., Tozza, S., Iovino, A., Iodice, R., Passaniti, C., Abbadessa, G., Bonavita, S., Leocani, L., Tedeschi, G., et al. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05396-8 · Cited by 37 · see citing works
Pareyson, D., Pantaleoni, C., Eleopra, R., Filippis, G. D., Moroni, I., Freri, E., Zibordi, F., Bulgheroni, S., Pagliano, E., Sarti, D., et al. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05252-9 · Cited by 31 · see citing works
Handberg, C., Werlauff, U., Højberg, A.-L., & Knudsen, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253715 · Cited by 21 · see citing works
A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases
Pisella, L. I., Fernandes, S., Solé, G., Stojkovic, T., Tard, C., Chanson, J., Bouhour, F., Salort‐Campana, E., Beaudonnet, G., Debergé, L., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02090-y · Cited by 17 · see citing works
Genuis, S. K., Luth, W., Bubela, T. M., & Johnston, W. S. W. (2022) · BMC Neurology · doi:10.1186/s12883-022-02662-w · Cited by 11 · see citing works
Telemedicine applied to neuromuscular disorders: focus on the COVID-19 pandemic era.
Giannotta, M., Petrelli, C., & Pini, A. (2022) · Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases · doi:10.36185/2532-1900-066 · Cited by 11 · see citing works
Sound‐based cough peak flow estimation in patients with neuromuscular disorders
Recasens, B. B., Corberó, A. B., Martínez‐Llorens, J., Guillén-Solà, A., Moreno, M. V., García‐Escobar, G., Umayahara, Y., Soh, Z., Tsuji, T., & Rubio, M. Á. (2023) · Muscle & Nerve · doi:10.1002/mus.27987 · Cited by 10 · see citing works
Self-citationAthamneh, M., Sa’di, Q., Aldabbour, B., Khader, Y. S., & Batayha, W. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00354-9 · Cited by 7 · see citing works
SECCION IX. Síndrome Post COVID-19: complicaciones tardías y rehabilitación
Saavedra, C. (2021) · Infectio · doi:10.22354/in.v25i4.979 · Cited by 8 · see citing works
User Involvement in Myasthenia Gravis Research
Gilhus, N. E., & Hovland, S. I. B. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.839769 · Cited by 6 · see citing works
Yu, M. K. L., Chan, H. S., Cheng, S. M. S., Leung, D., Chan, S. M., Suen, A. K. Y., Wong, W. H. S., Peiris, M. J. S., Lau, Y., & Duque, J. S. R. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2206278 · Cited by 5 · see citing works
Handberg, C., & Werlauff, U. (2023) · Neurodegenerative Disease Management · doi:10.2217/nmt-2022-0024 · Cited by 4 · see citing works
Fidelix, E. C., Santana, G. C., Barros, D. M. S., & Júnior, M. E. T. D. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1768161 · Cited by 4 · see citing works
Guerra, J. M., Esteban-Bueno, G., & Coca, J. R. (2021) · Acciones e Investigaciones Sociales · doi:10.26754/ojs_ais/ais.2021426230 · Cited by 4 · see citing works
Citarelli, G., Garofalo, C., Esposito, M. G., Torre, V., Magliano, L., & Politano, L. (2021) · Europe PMC (PubMed Central) · doi:10.36185/2532-1900-054 · Cited by 3 · see citing works
García, I., Martínez, Ó., Paz, J. F. L., Salgueiro, M., Rodríguez, A. A., Zorita, J., García-Sanchoyerto, M., & Amayra, I. (2023) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2023.01003 · Cited by 3 · see citing works
Yu, M. K. L., Chiu, A. Y. Y., Chau, S. K., Duque, J. S. R., Wong, W. H. S., & Chan, H. S. (2023) · Muscle & Nerve · doi:10.1002/mus.27982 · Cited by 3 · see citing works
Astrea, G., Marinella, G., Agosto, C., Gagliardi, D., Grandis, M., Giuliano, M. G., & Politano, L. (2021) · PubMed Central · doi:10.36185/2532-1900-060 · Cited by 3 · see citing works
Palazzo, L., Pompele, S., Rossi, M., Rossi, G., Spinoglio, S., & Testoni, I. (2022) · Pastoral Psychology · doi:10.1007/s11089-022-00997-2 · Cited by 3 · see citing works
Life Experiences in Neuromuscular Tracheotomized Patients in Times of Covid-19
Volpato, E., Pierucci, P., De Candia, M. L., Casparrini, M., Volpi, V., Pagnini, F., Carpagnano, G. E., & Banfi, P. (2023) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-221597 · Cited by 2 · see citing works
(2022) · Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases · doi:10.36185/2532-1900-075 · Cited by 2 · see citing works
Facing Amyotrophic Lateral Sclerosis Under Lockdown: The Experiences of Minors
Testoni, I., Palazzo, L., Tosatto, T., Sani, L., Rossi, G., & Ferizoviku, J. (2022) · Emerald Group Publishing Limited eBooks · doi:10.1108/s1530-353520220000019002 · Cited by 2 · see citing works
Öztürk, G., Karadağ‐Saygı, E., Unver, O. I., & Türkdoğan, D. (2022) · Turkish Journal of Physical Medicine and Rehabilitation · doi:10.5606/tftrd.2022.9105 · Cited by 1 · see citing works
Virtual EMG : Safe and Effective Remote Supervision and Reporting
Brouillette, K., Bacher, C., & Kassardjian, C. D. (2025) · Muscle & Nerve · doi:10.1002/mus.28479 · Cited by 1 · see citing works
Neuromuscular monitoring devices – where to go next?
Damian, M. S. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000977 · Cited by 1 · see citing works
Cardoso, J., de Paula, C. S., de Souza, M. A., & Mattiello‐Sverzut, A. C. (2022) · Acta Fisiátrica · doi:10.11606/issn.2317-0190.v29isupl.1a204881 · Cited by 1 · see citing works
Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights
Curry, M. A., Peterson, I. S., Belter, L. T., Sarr, F., Whitmire, S. M., Schroth, M. K., & Jarecki, J. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00516-2 · Cited by 1 · see citing works
Saito, T., Matsuo-Tezuka, Y., Sugitani, Y., Tajima, T., Fukao-Washino, J., Sakai, S., & Iwagami, M. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070818 · Cited by 1 · see citing works
Deenen, J. C. W., Kools, J., Greco, A., Thewissen, R., van de Put, W., Lanser, A., Joosten, L. A. B., Verbeek, A. L. M., van Engelen, B. G. M., & Voermans, N. C. (2024) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02443-3 · Cited by 1 · see citing works
The challenges faced by patients with hereditary myopathy during the COVID-19 pandemic
Türken, A., Çapar, H., Kurt, M. E., & Çakmak, C. (2024) · International Journal of Palliative Nursing · doi:10.12968/ijpn.2024.30.1.12 · Cited by 1 · see citing works
Aliyu, M., Saboor-Yaraghi, A., Getso, M., & Zohora, F. (2025) · InflammoPharmacology · doi:10.1007/s10787-025-01804-z · Cited by 1 · see citing works
Moura, J., Nascimento, H., Ferreira, I., Samões, R., Teixeira, C., Lopes, D., Boleixa, D., Sousa, A. P., Santos, E., & SILVA, A. C. F. D. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103893 · Cited by 1 · see citing works
Türken, A., Çapar, H., Kurt, M. E., & Çakmak, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1551748/v1
Forstein, A. R., Kolb, N., & Hehir, M. K. (2022) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2022.188
Yu, M. K. L., Chan, H. S. S., Cheng, S. M. S., Leung, D., Chan, S. M., Suen, A. K. Y., Wong, W. H. S., Peiris, M. J. S., Lau, Y., & Duque, J. S. R. (2022) · medRxiv · doi:10.1101/2022.11.29.22282857
Cruz, K. L. T., Petian-Alonso, D. C., Martins, E. J., & Mattiello‐Sverzut, A. C. (2022) · Acta Fisiátrica · doi:10.11606/issn.2317-0190.v29isupl.1a204879
Hieke, A., Spenner, M., Schmitz, F., Schumacher, A., Schröder, M., Klimas, R., Sgodzai, M., Brünger, J., Grüter, T., Gold, R., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11527-8
Changing Paradigm of Care of Neuromuscular Diseases in the COVID-19 Pandemic: A Scoping Review
Akulwar-Tajane, I. (2022) · Archives in Neurology & Neuroscience · doi:10.33552/ann.2022.12.000790
Access to Immunoglobulin Treatment for CIDP Patients During the COVID-19 Pandemic
Brissette, V., Poirier, L., Massie, R., Chalk, C., & Moore, F. G. A. (2023) · McGill Journal of Medicine · doi:10.26443/mjm.v21i1.964
Keeley, J., Stroobach, A., Huston, M., Wilson, A. C., Lam, J., Withers, A., van Veldhuisen, C., Baynam, G. S., & Downs, J. A. (2024) · Rare · doi:10.1016/j.rare.2024.100039
The evolution of patient management in infectious and autoimmune diseases in the post-COVID-19 era
Gutu, C., Sabanov, E., Grosu, O., Manole, E., Odainic, O., & Lisnic, V. (2025) · Bulletin of the Academy of Sciences of Moldova Medical Sciences · doi:10.52692/1857-0011.2025.3-83.39
It's Virtually Here: Telemedicine, Virtual Care, and Neuromuscular Disease
AANEM, Kassardjian, C. D., Desai, U., Živković, S. A., Simmons, Z., & Narayanaswami, P. (2026) · Muscle & Nerve · doi:10.1002/mus.70382
- Authors
- Bertran Recasens, B., & Rubio, M. A.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-26
- Volume
- 11
- Pages
- 588929-588929
- ISSN
- 1664-2295 (ISSN-L)
- PMC
- PMC7732578
- OpenAlex
- W3108460432
- Cited by
- 43
- References
- 52
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 10 · 2022: 16 · 2021: 10
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Neurology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
- Keywords
- neuromuscular disorders, COVID-19 pandemic, SARS-CoV-2, myasthenia gravis, amyotrophic lateral sclerosis, myopathy, chronic inflammatory demyelinating polyneuropathy, immunosuppressants, telemedicine, physical rehabilitation, continuity of care, diagnosis, economic impact, healthcare resource shortages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
